Ischaemic stroke
Not yet recruitingPhase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke
Phase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke
- Disease:Ischaemic stroke
- Substances:–
France- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Phase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke
France
FrancePhase 2 Study of Lirafugratinib in Patients with Previously Treated Unresectable Advanced Solid Tumors with FGFR2 Fusion (Excluding Cholangiocarcinoma)
FranceSafety and Tolerability Study of Subcutaneous Pegtibatinase in Adults and Children with Classical Homocystinuria (Phase 1/2)
FranceImmunogenicity and safety of RSV A/B prefusion F protein vaccine versus RSV F glycoprotein recombinant adjuvanted vaccine in lung and stem cell transplant recipients
FranceStudy of Camizestrant and Abemaciclib in Patients with ER‑positive HER2‑negative Metastatic Breast Cancer Who Show Rising ctDNA
FrancePhase 2/3 study of telisotuzumab adizutecan with drug combination versus standard care in adults with first‑line metastatic pancreatic ductal adenocarcinoma
FranceEffect of Stopping Long‑Term Azithromycin in Stable Non‑Cystic Fibrosis Bronchiectasis Patients: A Randomized Controlled Trial
FrancePatient‑chosen treatment vs routine surgery for adult uncomplicated acute appendicitis: trial of amoxicillin‑clavulanic acid versus appendectomy
FranceAnakinra for patients with myeloproliferative neoplasms resistant to cytoreductive therapy: a study to improve treatment response
FranceDurvalumab personalized consolidation immunotherapy after chemoradiotherapy in patients with stage III non‑small cell lung cancer
FranceStudy of IDE849, IDE‑161 and durvalumab evaluating safety and efficacy in patients with DLL3‑positive tumors including small cell lung cancer
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.